US Sunshine Act

Physician Payments Sunshine: Columbia Seeks to Join Global Transparency Trend

The Colombia Ministry of Health and Social Protection recently published a draft law which would require pharmaceutical and device manufacturers to disclose their payments and in-kind transfers to “those who participate in any manner in the provision, insurance, or education in the health sector.” The reports will be made public on a searchable database. Columbia’s draft resolution (translated to English) :

Read More »

Compliance Within Compliance: Grappling With Data Privacy In Spend Disclosure

Elias Okwara, Sr. Associate Global Regulatory Compliance at Health Market Science (HMS), and member of the Bertrand Act Think Tank, discusses “Compliance Within Compliance” in webinar series : In Part 1, Elias Okwara introduces the issue of data privacy within spend disclosure laws and regulations. In Part 2, Elias Okwara describes the unique challenges of the dual mandate of complying with data privacy and spend disclosure laws in Europe, Australia and Japan. In Part 3, Elias Okwara provides organizations discusses the risk of non-compliance and FAQ’s that companies should consider when implementing a global spend disclosure program.

Read More »

Total Transparency Manifesto : un groupe de médecins américains dévoile tout

Aux Etats-Unis, la transparence ne s’arrête jamais. Après le Sunshine Act, qui obligeait l’industrie pharmaceutique à rendre publics tous les paiements effectués en faveur de médecins, voici maintenant le Total Transparency Manifesto. Il s’agit d’une initiative lancée par le Dr Leana Wen, urgentiste américaine et militante des droits des patients. Cette praticienne appelle ses confrères à dévoiler volontairement combien ils reçoivent de la part des laboratoires, mais aussi à divulguer la manière dont ils sont rémunérés. Pour lire l’article du Quotidien du Médecin

Read More »

Obamacare Sunshine Act sheds light on $3.5B paid to doctors

US doctors and teaching hospitals received nearly $3.5 billion from pharmaceutical companies and medical device manufacturers over the last five months of 2013, according to a partial set of data released Tuesday by the federal government. The data mark the first disclosure of anything approaching comprehensive information on the once-confidential financial ties between doctors and drug- and device-makers. The data include 4.4 million payments and other transfers of value by drug- and device-makers to some 546,000 U.S. physicians and 1,360 teaching hospitals made between Aug. 1, 2013, and Dec. 31, 2013. To read the article by Peter Frost, Alex Richards, …

Read More »